Physician
Hematology
Dr. Daniel W. Bowles, MD
|
|
Give Review
Doctor Daniel W. Bowles, MD works in the field of Hematology. He attended University of Colorado Denver School of Medicine. University of Colorado Denver School of Medicine is a top medical college. University of Colorado Denver School of Medicine has a rank of 35 in research and a 8 in primary care He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Daniel Bowles is a published doctor. He published 22 publications, including: 'Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.' Daniel Bowles is registered with Medicare.
Publications
- A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck Squamous cell carcinoma.
- Phase 1 Dose-Escalation Trial of the Oral Investigational Hedgehog Signaling Pathway Inhibitor TAK-441 in Patients with Advanced Solid Tumors.
- Distress among caregivers of phase I trial participants: a cross-sectional study.
- A Randomized, Phase 2 Trial of Docetaxel with or without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Relapsed or Metastatic ...
- Occult primary, version 3.2014.
- A multicenter phase 1 study of PX-866 and cetuximab in patients with metastatic colorectal carcinoma or recurrent/metastatic Squamous cell carcinoma of the head and neck.
- Novel treatments for head and neck Squamous cell carcinoma: preclinical identification and clinical investigation.
- Phase 1 study of Oral rigosertib (ON 01910.Na), a dual inhibitor of the PI3K and Plk1 pathways, in adult patients with advanced solid malignancies.
- Afatinib for the treatment of patients with EGFR-positive non-small cell lung Cancer.
- A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours.
- The dual pathway inhibitor rigosertib is effective in direct-patient tumor xenografts of head and neck Squamous cell carcinomas.
- Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck Cancer.
- A patient tumor transplant model of squamous cell Cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins.
- The intersection between cannabis and Cancer in the United States.
- Locoregional recurrence of an HPV-positive Squamous cell carcinoma of the head and neck.
- A young woman with a small ER-positive breast Cancer, a micrometastatic axillary lymph node, and an intermediate oncotype DX recurrence score.
- Mitoxantrone-associated acute myelogenous leukemia in a patient with high-risk adenocarcinoma of the Prostate: a case report and brief review.
- Enterobacter Cancerogenus bacteremia in a patient with poor dentition, cirrhosis, and a variceal bleed.
- New phosphatidylinositol 3-kinase inhibitors for Cancer.
- Multi-targeted tyrosine kinase inhibitors in clinical development: focus on XL-184 (cabozantinib).
- Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck Cancer according to the National Cancer Data Base.
Schools
University Of Colorado Denver School Of Medicine
University Of Colorado
Conditions Treated
- Anemia
- ENT Cancer
- Laryngeal Cancer
- Liver Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Colorado -
University of Colorado Denver School of Medicine
Drug Facts
| NPI NUMBER | 1720134315 | |
| NPPES Provider LastName | BOWLES | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 800452545 | |
| NPPES Provider State | CO | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 75.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1720134315 |
| Last Name Of The Provider | BOWLES |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
|
Dr. Daniel A. Pollyea, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Robert H. Allen, MD |
|
Dr. Peter Kabos, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Catherine E. Klein, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Manoj Pillai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eun-Kyung Im, MD |
|
|
Dr. Jan L. Gray, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Madeleine A. Kane, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Angela M. Davies, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|